Utilizing Deep Learning to Distinguish Between Non-Tuberculous Mycobacterial Lung Disease and Pulmonary Tuberculosis via Chest CT Imaging - Report - MDSpire

Utilizing Deep Learning to Distinguish Between Non-Tuberculous Mycobacterial Lung Disease and Pulmonary Tuberculosis via Chest CT Imaging

  • By

  • Bingchuan Hu

  • Bin Wu

  • Yuwei Zhou

  • Zherui Shao

  • Qingning Wang

  • Binyu Luo

  • Zhuo Yu

  • Dawei Zheng

  • April 21, 2026

  • 0 min

Share

Clinical Report: Utilizing Deep Learning to Distinguish NTM-LD from PTB

Overview

This study developed a 3D ResNeXt deep learning model to differentiate non-tuberculous mycobacterial lung disease (NTM-LD) from pulmonary tuberculosis (PTB) using chest CT imaging. The model demonstrated superior accuracy and interpretability compared to traditional methods and other deep learning architectures.

Background

Differentiating NTM-LD from PTB is clinically significant due to their overlapping symptoms and imaging features, which can lead to misdiagnosis and inappropriate treatment. Accurate differentiation is crucial for optimizing patient management and improving outcomes, as the therapeutic approaches for these diseases differ markedly. Current diagnostic methods are often time-consuming and lack sensitivity, highlighting the need for advanced imaging techniques.

Data Highlights

ModelAUC (Training Set)Accuracy (Training Set)AUC (Test Set)Accuracy (Test Set)
3D ResNeXt0.890.890.830.84

Key Findings

  • The 3D ResNeXt model outperformed six other deep learning architectures in distinguishing NTM-LD from PTB.
  • Statistical analysis confirmed the model's superiority with p < 0.05 across all comparisons.
  • Key imaging features identified included nodular bronchiectasis and tree-in-bud opacities for NTM-LD, and thick-walled cavitary lesions for PTB.
  • The model achieved an AUC of 0.83 and accuracy of 0.84 on the independent test set.
  • Gradient-weighted Class Activation Mapping (Grad-CAM) provided interpretable visualizations of disease-specific features.

Clinical Implications

The 3D ResNeXt model offers a promising tool for clinicians to enhance the accuracy of differential diagnoses between NTM-LD and PTB, potentially leading to more appropriate treatment strategies. Its ability to provide interpretable results may also assist radiologists in making informed decisions based on imaging findings.

Conclusion

The study highlights the potential of deep learning models in improving diagnostic accuracy for respiratory diseases. Further validation through prospective multicenter studies is necessary to establish the model's clinical utility.

References

  1. European Radiology, 2023 -- MI-DenseCFNet: A Deep Learning Approach for Multimodal Diagnosis of Pneumonia Caused by Aureus and Aspergillus
  2. Identifying drug-resistant tuberculosis through chest X-ray analysis, 2018
  3. European Radiology, 2023 -- Impact of Reduced CT Radiation Dose on AI-Based Assessment of Incidental Lung Nodules for Malignancy
  4. ATS/ERS/ESCMID/IDSA Clinical Practice Guideline on the Treatment of Nontuberculous Mycobacterial Pulmonary Disease
  5. npj Digital Medicine — Automated detection of radiolucent foreign body aspiration on chest CT using deep learning
  6. Differentiating NTM pulmonary disease from pulmonary tuberculosis
  7. Nontuberculous mycobacterial pulmonary disease presenting as bronchiolitis pattern on CT without cavity or bronchiectasis | BMC Pulmonary Medicine | Full Text
  8. Frontiers | Revolutionizing diagnosis of pulmonary Mycobacterium tuberculosis based on CT: a systematic review of imaging analysis through deep learning

Original Source(s)

Related Content